CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood.

Int J Mol Sci · 2020 · PMC7460610 · PMID 32824692

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

showed a trendp = 0.052so close (0.05 < p ≤ 0.1)

Although no correlation was observed between the sCD163 levels and TNM stage in a Spearman’s rho correlation test ( p = 0.141), an intergroup analysis revealed that patients with TNM stage IV tumors showed a trend towards higher sCD163 levels compared to TNM stage 0/I patients ( p = 0.052, Figure 2 B).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.